Reports
Sale
Global Hematology Analyzers and Reagents Market Size, Share, Analysis: By Product and Services: Products, Reagents and Consumables; By Technology: Automated Hematology Analyzers, Flow Cytometry, Specialized Hematology Analyzers; By Applications; By End User; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
Global Hematology Analyzers and Reagents Market Outlook
The global hematology analyzers and reagents market size was valued at USD 7.31 billion in 2023, driven by the rising number of blood disorders across the globe. The market size is anticipated to grow at a CAGR of 6.0% during the forecast period of 2024-2032 to achieve a value of USD 12.36 billion by 2032.
Hematology Analyzers and Reagents: Introduction
Hematology analyzers are used to perform a test, called complete blood count, with accuracy. This test is the first basic test that a physician asks someone to know about their health history.
Global Hematology Analyzers and Reagents Market Analysis
The rising prevalence of anemia is primarily driving the growth of the market. According to WHO, anaemia affects 571 million women and 269 million young children worldwide. The increasing initiatives by organization such as WHO to improve the accessibility status of healthcare related to anemia is driving the hematology analyzers and reagents and market growth. For instance, WHO has launched a comprehensive framework on reducing anemia. WHO has asked countries to speed up the process to reduce anaemia prevalence in women by 2025.
The increasing technological advancements in the hematology analyzers is leading to increase in demand as it can easily increase the capabilities of the laboratory. The integration of advanced technologies, such as artificial intelligence in hematology analyzers, is aiding the global hematology analyzers and reagents and market growth as it reduces the chances of information overload and confusion. The increasing focus of key players on developing new and improved technologically advanced hematology analyzers is also driving the market growth.
Moreover, the rising number of clinical trials and research studies to improve the efficacy of hematology analyzers and reagents is directly contributing to the growth of the market. With increasing focus of key players on development of new technologies, the launch of new products in the market is aiding the growth of the market.
Global Hematology Analyzers and Reagents Market Segmentations
Market Breakup by Product and Services
- Products
- Hematology Analyzers
- 5-Part and 6-Part Hematology Analyzers
- Point of Care Testing Hematology Analyzers
- Semi-Automated Hematology Analyzers
- Automated Cell Counters
- Flow Cytometers
- Others
- Reagents and Consumables
- Hematology Reagents
- Consumables
- Controls and Calibrators
- Slide Stainer’s
- Others
Market Breakup by Technology
- Automated Hematology Analyzers
- Flow Cytometry
- Specialized Hematology Analyzers
Market Breakup by Applications
- Anemia
- Blood Cancer
- Hemorrhagic Conditions
- Infection-Related Conditions
- Immune System Related Conditions
- Others
Market Breakup by End User
- Hospital Laboratories
- Blood Banks
- Commercial Service Providers
- Government Reference Laboratories
- Research and Academic Institute
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Hematology Analyzers and Reagents Market Overview
The increasing prevalence of blood related disorders, like anemia and leukemia, is primarily driving the market growth. According to leukemia and lymphoma society, nearly 59,610 people are predicted to be diagnosed with leukemia by the end of 2024. The rising incidence of blood disorders such as haemophilia and blood clots across the globe are also driving the market growth as the increase in these disorders is adding further value to the overall global hematology analyzers and reagents market share. The rise in hemorrhagic conditions causing excessive bleeding internally in body organs is also anticipated to aid the demand for hematology analyzers and reagents.
Other than the rising prevalence of these disorders, the rapid technological advancements are also likely to propel the growth of the market in the coming years. Governments and key players across the globe are investing funds and efforts to develop more advanced products, which would significantly contribute to the overall development of the market during the forecast period.
Hematology Analyzers and Reagents Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Sysmex Corporation
- Siemens Healthineers
- Beckman Coulter
- Roche Diagnostics
- HORIBA Medical
- Nihon Kohden Corporation
- Boule Diagnostics
- Mindray Medical International Limited
- Bio-Rad Laboratories
- Ortho Clinical Diagnostics
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Diatron
- EKF Diagnostics
- Drew Scientific Inc.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product and Services |
|
| Breakup by Technology |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Hematology Analyzers and Reagents Market Overview
3.1 Global Hematology Analyzers and Reagents Market Historical Value (2017-2023)
3.2 Global Hematology Analyzers and Reagents Market Forecast Value (2024-2032)
4 Global Hematology Analyzers and Reagents Market Landscape
4.1 Global Hematology Analyzers and Reagents Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Hematology Analyzers and Reagents Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Hematology Analyzers and Reagents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Hematology Analyzers and Reagents Market Segmentation
6.1 Global Hematology Analyzers and Reagents Market by Product and Services
6.1.1 Market Overview
6.1.2 Products
6.1.2.1 Hematology Analyzers
6.1.2.1.1 5-Part and 6-Part Hematology Analyzers
6.1.2.1.2 Point of Care Testing Hematology Analyzers
6.1.2.1.3 Semi-Automated Hematology Analyzers
6.1.2.2 Automated Cell Counters
6.1.2.3 Flow Cytometers
6.1.2.4 Others
6.1.3 Reagents and Consumables
6.1.3.1 Hematology Reagents
6.1.3.2 Consumables
6.1.3.3 Controls & Calibrators
6.1.3.4 Slide Stainer’s
6.1.3.5 Others
6.2 Global Hematology Analyzers and Reagents Market by Technology
6.2.1 Market Overview
6.2.2 Automated Hematology Analyzers
6.2.3 Flow Cytometry
6.2.4 Specialized Hematology Analyzers
6.3 Global Hematology Analyzers and Reagents Market by Applications
6.3.1 Market Overview
6.3.2 Anemia
6.3.3 Blood Cancer
6.3.4 Hemorrhagic Conditions
6.3.5 Infection-Related Conditions
6.3.6 Immune System Related Conditions
6.3.7 Others
6.4 Global Hematology Analyzers and Reagents Market by End User
6.4.1 Market Overview
6.4.2 Hospital Laboratories
6.4.3 Blood Banks
6.4.4 Commercial Service Providers
6.4.5 Government Reference Laboratories
6.4.6 Research and Academic Institute
6.4.7 Others
6.5 Global Hematology Analyzers and Reagents Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Hematology Analyzers and Reagents Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Hematology Analyzers and Reagents Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Hematology Analyzers and Reagents Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Hematology Analyzers and Reagents Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Hematology Analyzers and Reagents Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Sysmex Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Siemens Healthineers
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Beckman Coulter
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Roche Diagnostics
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 HORIBA Medical
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Nihon Kohden Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Boule Diagnostics
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Mindray Medical International Limited
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Bio-Rad Laboratories
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Ortho Clinical Diagnostics
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Diatron
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 EKF Diagnostics
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Drew Scientific Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Hematology Analyzers and Reagents Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 7.31 billion in 2023, driven by the increasing geriatric population.
The market is anticipated to grow at a CAGR of 6% during the forecast period of 2024-2032, and likely to reach a market value of USD 12.36 billion by 2032.
The increasing blood disorders or diseases such as blood cancer and haemophilia is driving the market demand.
The increasing technological advancements in hematology analyzers is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The products and services available in the market include products, reagents and consumables.
Different technologies include automated hematology analyzers, flow cytometry, and specialized hematology analyzers.
They find wide applications in anemia, blood cancer, hemorrhagic conditions, infection-related conditions, and immune system related conditions, among others.
The end users in the market include hospital laboratories, blood banks, commercial service providers, government reference laboratories, research and academic institutes, among others.
Key players involved in the market are Abbott Laboratories, Sysmex Corporation, Siemens Healthineers, Beckman Coulter, Roche Diagnostics, HORIBA Medical, Nihon Kohden Corporation, Boule Diagnostics, Mindray Medical International Limited, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Diatron, Drew Scientific Inc., and EKF Diagnostics.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER